The involvement of MCU in cancer progression was demonstrated in vivo by Tosatto et al., who showed that breast cancer tumor xenografts derived from MCU-deleted cells grew more slowly and were less likely to metastasize (92). The gene discussed is MCU; the disease is cancer.